<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pcbi</journal-id><journal-id journal-id-type="flc">plcb</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.pcbi.0010054</article-id><article-id pub-id-type="sici">plcb-01-05-08</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Computational Biology</subject><subject>Oncology</subject><subject>Cell Biology</subject><subject>Computational Biology/Systems Biology</subject></subj-group></article-categories><title-group><article-title>Ultrasensitization: Switch-Like Regulation of Cellular Signaling by Transcriptional Induction</article-title><alt-title alt-title-type="running-head">Ultrasensitization</alt-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Legewie</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref><xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Blüthgen</surname><given-names>Nils</given-names></name><xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Schäfer</surname><given-names>Reinhold</given-names></name><xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Herzel</surname><given-names>Hanspeter</given-names></name><xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref></contrib></contrib-group><aff id="aff1">
				<label>1</label><addr-line> Institute for Theoretical Biology, Humboldt University, Berlin, Germany
			</addr-line></aff><aff id="aff2">
				<label>2</label><addr-line> Laboratory of Molecular Tumor Pathology, Charité, Berlin, Germany
			</addr-line></aff><contrib-group><contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Miyano</surname><given-names>Satoru</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Tokyo, Japan</aff><author-notes><fn fn-type="con" id="ack2"><p>SL conceived and performed initial simulations. SL, NB, RS, and HH discussed preliminary results, suggested further calculations, and wrote the paper.</p></fn><corresp id="cor1">* To whom correspondence should be addressed. E-mail: <email xlink:type="simple">s.legewie@biologie.hu-berlin.de</email></corresp><fn fn-type="conflict" id="ack1"><p> The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2005</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2005</year></pub-date><pub-date pub-type="epreprint"><day>26</day><month>9</month><year>2005</year></pub-date><volume>1</volume><issue>5</issue><elocation-id>e54</elocation-id><history><date date-type="received"><day>9</day><month>5</month><year>2005</year></date><date date-type="accepted"><day>26</day><month>9</month><year>2005</year></date></history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2005</copyright-year><copyright-holder>Legewie et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>Cellular signaling networks are subject to transcriptional and proteolytic regulation under both physiological and pathological conditions. For example, the expression of proteins subject to covalent modification by phosphorylation is known to be altered upon cellular differentiation or during carcinogenesis. However, it is unclear how moderate alterations in protein expression can bring about large changes in signal transmission as, for example, observed in the case of haploinsufficiency, where halving the expression of signaling proteins abrogates cellular function. By modeling a fundamental motif of signal transduction, the phosphorylation–dephosphorylation cycle, we show that minor alterations in the concentration of the protein subject to phosphorylation (or the phosphatase) can affect signal transmission in a highly ultrasensitive fashion. This “ultrasensitization” is strongly favored by substrate sequestration on the catalyzing enzymes, and can be observed with experimentally measured enzymatic rate constants. Furthermore, we show that coordinated transcription of multiple proteins (i.e., synexpression) within a protein kinase cascade results in even more pronounced all-or-none behavior with respect to signal transmission. Finally, we demonstrate that ultrasensitization can account for specificity and modularity in the regulation of cellular signal transduction. Ultrasensitization can result in all-or-none cell-fate decisions and in highly specific cellular regulation. Additionally, switch-like phenomena such as ultrasensitization are known to contribute to bistability, oscillations, noise reduction, and cellular heterogeneity.</p></abstract><abstract abstract-type="synopsis"><title>Synopsis</title><sec id="st1"><title/><p>Hormones and other external stimuli induce cellular transitions such as cell division or differentiation by regulating gene expression. Hormone-induced cellular transitions are known to occur in a switch-like fashion: while weak background stimuli are rejected, cellular transitions proceed fully as soon as a threshold hormone concentration is exceeded. Earlier studies have described several mechanisms whereby such a switch-like behavior can be realized in intracellular communication via signal transduction networks, which convert hormonal signals into alterations in gene expression.</p><p>The authors demonstrate how switch-like behavior can be further enhanced downstream of hormone-induced gene expression. They show that even minor (hormone-induced) alterations in gene expression can dramatically affect the activity of intracellular signal transduction networks, and thereby modify cellular behavior. This phenomenon has been termed “ultrasensitization.”</p><p>Ultrasensitization can explain the pronounced dosage sensitivity observed for many disease-associated signal transduction proteins: for example, the mutation of one of two alleles (gene copies), resulting in a 2-fold reduction of gene expression, can already initiate disease progression. Although such sensitivity towards mutations is potentially harmful, the fact that cells nevertheless exhibit ultrasensitization suggests that somehow cells benefit from ultrasensitization. The authors illustrate how ultrasensitization improves the specificity and efficiency of cell-to-cell communication and contributes to cellular memory.</p></sec></abstract><counts><page-count count="10"/></counts><!--===== Restructure custom-meta-wrap to custom-meta-group =====--><custom-meta-group><custom-meta><meta-name>Citation:</meta-name><meta-value>Legewie S, Blüthgen N, Schäfer R, Herzel H (2005) Ultrasensitization: Switch-like regulation of cellular signaling by transcriptional induction. PLoS Comput Biol 1(5): e54.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Cellular signal transduction exhibits two layers of regulation: upstream stimuli such as extracellular peptide hormones activate intracellular signaling intermediates (e.g., mitogen-activated protein kinases), which in turn induce intracellular responses (e.g., activated transcription factors) as indicated in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>A. This type of regulation, which usually operates on the time scale of minutes, will be termed “fast regulation” in this paper. Fast regulation involves the posttranslational modification of pre-existing protein pools in order to transduce signals to the nucleus. Responses induced by fast regulation (Response 1), such as activated transcription factors, often in turn alter the total abundance of their own activators (Intermediate 1) or that of intermediates in heterologous cascades (Intermediate 2), e.g., owing to induced mRNA/protein synthesis or to degradation (<xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>A). For example, signal transduction pathways in the immune system alter the concentration of their own constituents by transcriptional positive or negative feedback to bring about sensitization [<xref ref-type="bibr" rid="pcbi-0010054-b01">1</xref>] or desensitization [<xref ref-type="bibr" rid="pcbi-0010054-b02">2</xref>]. Likewise, cyclic guanosine monophosphate signaling affects the heterologous mitogenic cascades via “transcriptional crosstalk” by inducing the MKP-1 phosphatase and cyclin-dependent kinase inhibitors [<xref ref-type="bibr" rid="pcbi-0010054-b03">3</xref>]. Owing to the long half-lives of most mRNAs [<xref ref-type="bibr" rid="pcbi-0010054-b04">4</xref>] and proteins [<xref ref-type="bibr" rid="pcbi-0010054-b05">5</xref>], this type of regulation operates on the time scale of hours in most (but not all) cases and thus will be referred to as “slow regulation” here.</p><fig id="pcbi-0010054-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0010054.g001</object-id><label>Figure 1</label><caption><title>Slow and Fast Regulation of Cellular Signal Transduction</title><p>(A) Schematic representation of cellular signal transduction. Upstream stimuli (e.g., hormones) result in altered gene expression by eliciting rapid intracellular responses such as transcription factors (fast regulation). The resulting changes in protein expression often in turn affect cellular signal processing of upstream inputs via transcriptional feedback or crosstalk (slow regulation).</p><p>(B) Schematic representation of a phosphorylation–dephosphorylation cycle, where the kinase K and the phosphatase P catalyze the (de)phosphorylation of the substrate, S. Hormonal stimulation (i.e., fast regulation) was modeled by altering the total kinase concentration, K<sub>tot</sub> = K + S<sub>0</sub>K, and the steady-state concentration of free phosphorylated substrate, S<sub>1</sub>, was taken as the response. The impact of slow regulation was modeled by varying the concentration of the substrate (S<sub>tot</sub> = S<sub>0</sub> + S<sub>0</sub>K + S<sub>1</sub> + S<sub>1</sub>P) or that of the phosphatase (P<sub>tot</sub> = P + S<sub>1</sub>P).</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.g001" xlink:type="simple"/></fig><p><xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>A shows a simplified view of signal transduction: upstream stimuli such as hormones (i.e., fast regulation) induce gene expression (i.e., slow regulation), which in turn alters cellular signal processing. Previous theoretical and experimental studies (e.g., [<xref ref-type="bibr" rid="pcbi-0010054-b06">6</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b07">7</xref>]) have mainly analyzed how fast regulation influences slow regulation, while downstream effects, i.e., the impact of slow regulation on fast regulation, are less well investigated. However, slow regulation is probably equally important, since the expression of phosphoproteins is altered during a variety of physiological processes such as differentiation [<xref ref-type="bibr" rid="pcbi-0010054-b08">8</xref>], development [<xref ref-type="bibr" rid="pcbi-0010054-b09">9</xref>], apoptosis [<xref ref-type="bibr" rid="pcbi-0010054-b10">10</xref>], long-term potentiation [<xref ref-type="bibr" rid="pcbi-0010054-b11">11</xref>], the cell cycle [<xref ref-type="bibr" rid="pcbi-0010054-b12">12</xref>], and the circadian rhythm [<xref ref-type="bibr" rid="pcbi-0010054-b13">13</xref>]. Furthermore, the deregulated expression of wild-type phosphoproteins has been shown to be correlated with diseases such as diabetes [<xref ref-type="bibr" rid="pcbi-0010054-b08">8</xref>] and cancer [<xref ref-type="bibr" rid="pcbi-0010054-b14">14</xref>].</p><p>At a first glance, one may expect that altered expression of Intermediate 1 (i.e., slow regulation) affects steady-state signal transmission via Intermediate 1 (i.e., fast regulation) in a linear fashion (<xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>A). However, recent research suggests that strong nonlinearity is observed at least in some cases: a variety of tumor-suppressor genes involved in cellular signal transduction do not follow Knudson's two-hit hypothesis, i.e., they do not require a homozygotic loss of both alleles to support tumor progression. Instead, loss of a single copy, i.e., halving protein expression, is sufficient to abrogate tumor-suppressor function and this phenomenon has been termed haploinsufficiency [<xref ref-type="bibr" rid="pcbi-0010054-b15">15</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b16">16</xref>]. This suggests that the expression of signaling proteins (i.e., slow regulation) affects signal transmission (i.e., fast regulation) in a highly switch-like fashion. As increased signal transmission elicited by transcriptional induction has been referred to as sensitization [<xref ref-type="bibr" rid="pcbi-0010054-b01">1</xref>], such ultrasensitive regulation will be referred to here as “ultrasensitization.”</p><p>Available experimental data suggest that ultrasensitization is physiologically advantageous: receptor-tyrosine kinases, which elicit different cellular responses, are known to induce broadly overlapping sets of immediate early genes, although the amplitude of the immediate early gene-induction is receptor-specific [<xref ref-type="bibr" rid="pcbi-0010054-b17">17</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b18">18</xref>]. Ultrasensitization allows cells to discriminate such minor differences in immediate early gene expression (i.e., in slow regulation), and thus confers specificity to receptor-tyrosine kinase signaling. In addition, even saturating hormone concentrations induce/repress the vast majority of target mRNAs less than 10-fold (e.g., [<xref ref-type="bibr" rid="pcbi-0010054-b19">19</xref>]). Thus, the stimulus-response of hormone-induced transcription exhibits significant basal activation, so that mRNA induction (i.e., slow regulation) is relatively insensitive towards extracellular hormone concentrations [<xref ref-type="bibr" rid="pcbi-0010054-b20">20</xref>]. In such cases, ultrasensitization can dramatically increase the cellular effects of extracellular hormone administration and may help to establish all-or-none cell-fate decisions. Finally, strong nonlinearities such as ultrasensitization are known to contribute to bistability, oscillations, noise reduction, and cellular heterogeneity (see <xref ref-type="sec" rid="s3">Discussion</xref>).</p><p>Phosphorylation is the most common mode of eukaryotic information transfer, and it has been estimated that one third of all cellular proteins are phosphorylated [<xref ref-type="bibr" rid="pcbi-0010054-b21">21</xref>]. As several haploinsufficient tumor suppressors encode phosphoproteins (e.g., p53, BRCA1, H2AX, and pRb), or phosphatases (PTEN), we were interested in whether ultrasensitization can occur in a simple phosphorylation–dephosphorylation cycle (<xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B). We show here that pronounced ultrasensitization is possible with experimentally measured kinetic constants, particularly in the parameter range where the substrate–enzyme ratio is such that the majority of the substrate subject to (de)phosphorylation is sequestered by the catalyzing enzymes. Furthermore, we show that coordinated transcription of multiple proteins (i.e., synexpression) within a kinase cascade can result in even more pronounced ultrasensitization. Finally, we demonstrate that ultrasensitization can account for specificity and modularity in the regulation of cellular signal transduction.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Ultrasensitization in a Phosphorylation–Dephosphorylation Cycle</title><p>As outlined in the Introduction, we were interested in the means by which altered protein expression (i.e., slow regulation) affects signal transmission (i.e., fast regulation) by a simple phosphorylation–dephosphorylation cycle depicted in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B. Protein (de)phosphorylation was modeled using the irreversible Michaelis-Menten mechanism, where each elementary step is described by mass-action kinetics. As indicated in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B, the free unphosphorylated substrate, S<sub>0</sub>, reversibly associates with the free kinase, K, and the resulting kinase–substrate complex, S<sub>0</sub>K, may irreversibly form the free phosphorylated substrate, S<sub>1</sub>, thereby recycling the free kinase, K. Likewise, the free phosphorylated substrate, S<sub>1</sub>, is subject to dephosphorylation by the phosphatase and this occurs via formation of the substrate–phosphatase complex, S<sub>1</sub>P (see <xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref> for the differential equations). Importantly, our modeling approach takes substrate sequestration on the enzyme–substrate complexes, S<sub>0</sub>K and S<sub>1</sub>P, into account, which is in contrast to the well-known Michaelis-Menten approximation for enzyme catalysis, where the substrate concentration is assumed to significantly exceed that of the enzyme. The impact of upstream stimuli such as extracellular hormones (i.e., fast regulation) was modeled by altering the total kinase concentration, K<sub>tot</sub> = K + S<sub>0</sub>K, and the steady-state concentration of the free phosphorylated substrate, S<sub>1</sub>, was taken as the response of the system. As we assume that the phosphatase competes with downstream effectors for a single docking site in the substrate (e.g., [<xref ref-type="bibr" rid="pcbi-0010054-b22">22</xref>]), the substrate–phosphatase complex, S<sub>1</sub>P, does not contribute to the response.</p><p>To understand how protein expression (i.e., slow regulation) affects signal transmission (i.e., fast regulation), the steady-state stimulus response of the model depicted in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B was plotted for varying substrate expression, S<sub>tot</sub> = S<sub>0</sub> + S<sub>0</sub>K + S<sub>1</sub> + S<sub>1</sub>P. Then, the steady-state activation levels (S<sub>1</sub>) for a given stimulus (K<sub>tot</sub>) before and after induction of the substrate (S<sub>tot</sub>) were compared. As indicated by the right arrow in <xref ref-type="fig" rid="pcbi-0010054-g002">Figure 2</xref>, a 5-fold induction of the substrate expression can bring about a 94-fold increase in the steady-state activation level upon strong stimulation (K<sub>tot</sub> &gt;&gt; P<sub>tot</sub>). Ultrasensitization is even more pronounced upon intermediate stimulation, since then a 5-fold altered substrate expression can bring about a 325-fold increase in the steady-state activation level. By contrast, nonlinearity disappears for very weak stimulation, i.e., for K<sub>tot</sub> → 0, where the absolute activation levels are negligible (<xref ref-type="fig" rid="pcbi-0010054-g002">Figure 2</xref>).</p><fig id="pcbi-0010054-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0010054.g002</object-id><label>Figure 2</label><caption><title>Ultrasensitization in a Phosphorylation–Dephosphorylation Cycle</title><p>Stimulus-response of the phosphorylation–dephosphorylation cycle depicted in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B for varying substrate expression levels, S<sub>tot</sub> = S<sub>0</sub> + S<sub>0</sub>K + S<sub>1</sub> + S<sub>1</sub>P, on a double-logarithmic scale. The relative alterations in the response, S<sub>1</sub>, for a given stimulus, K<sub>tot</sub> = K + S<sub>0</sub>K, elicited by a 5-fold change in substrate expression are indicated next to the vertical arrows. Parameters chosen: k<sub>on,K</sub> = k<sub>off,P</sub> = k<sub>cat,P</sub> = 0.01; k<sub>off,K</sub> = k<sub>cat,K</sub> = 1; k<sub>on,P</sub> = 1.6; P<sub>tot</sub> = 1.25.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.g002" xlink:type="simple"/></fig><p>Thus, we proved that protein expression (i.e., slow regulation) can affect signal transmission (i.e., fast regulation) in a highly nonlinear fashion provided that stimulation is sufficiently strong. In other words, ultrasensitization is possible in a phosphorylation–dephosphorylation cycle, and transfection experiments in living cells support this conclusion [<xref ref-type="bibr" rid="pcbi-0010054-b23">23</xref>].</p></sec><sec id="s2b"><title>Ultrasensitization Due to Substrate Sequestration</title><p>To gain further insight into ultrasensitization in a phosphorylation–dephosphorylation cycle, we analyzed steady-state signal transmission upon strong stimulation (K<sub>tot</sub> &gt;&gt; P<sub>tot</sub>), since an analytical expression for the response, S<sub>1</sub>, could be obtained in this limit (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref>):</p><disp-formula id="pcbi-0010054-e001"><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.e001" xlink:type="simple"/><!-- <mml:math display='block'><mml:mrow><mml:mfrac><mml:mrow><mml:munder><mml:mrow><mml:mi>lim</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mn>K</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mn>P</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext></mml:mrow></mml:msub><mml:mo>&rarr;</mml:mo><mml:mi>&infin;</mml:mi></mml:mrow></mml:munder><mml:mo>(</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mn>S</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>&equals;</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:mo>&sdot;</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&minus;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mn>S</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext><mml:mo>,</mml:mo><mml:mn>T</mml:mn></mml:mrow></mml:msub><mml:mo>&plus;</mml:mo><mml:msub><mml:mn>K</mml:mn><mml:mrow><mml:mn>m</mml:mn><mml:mo>,</mml:mo><mml:mn>P</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mn>S</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>&plus;</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&minus;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mn>S</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext><mml:mo>,</mml:mo><mml:mn>T</mml:mn></mml:mrow></mml:msub><mml:mo>&plus;</mml:mo><mml:msub><mml:mn>K</mml:mn><mml:mrow><mml:mn>m</mml:mn><mml:mo>,</mml:mo><mml:mn>P</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mn>S</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>&plus;</mml:mo><mml:mn>4</mml:mn><mml:mo>&sdot;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mn>K</mml:mn><mml:mrow><mml:mn>m</mml:mn><mml:mo>,</mml:mo><mml:mn>P</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mn>S</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:msqrt></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math> --></disp-formula><p>Here, the Michaelis-Menten constant of the phosphatase, K<sub>M,P</sub>, and the threshold substrate concentration, S<sub>tot,T</sub>, where ultrasensitization occurs (see below), are given by:</p><disp-formula id="pcbi-0010054-e002"><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.e002" xlink:type="simple"/><!-- <mml:math display='block'><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>&equals;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>&plus;</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mtext>,&thinsp; </mml:mtext><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mtext>,&thinsp; </mml:mtext><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mtext>&thinsp;and&thinsp;</mml:mtext><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>&equals;</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>&sdot;</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&plus;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math> --></disp-formula><p>The rate constants k<sub>on</sub>, k<sub>off</sub>, and k<sub>cat</sub> describe the individual steps of kinase (K) or phosphatase (P) catalysis as indicated in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B, and P<sub>tot</sub> = P + S<sub>1</sub>P is the total phosphatase expression level.</p><p>As shown in <xref ref-type="fig" rid="pcbi-0010054-g003">Figure 3</xref>, a large relative change in signal transmission according to <xref ref-type="disp-formula" rid="pcbi-0010054-e001">Equation 1</xref> from S<sub>1</sub> &lt;&lt; S<sub>tot</sub> to S<sub>1</sub> ≈ S<sub>tot</sub> can be observed upon minor increases in substrate expression. As this dramatic relative change occurs in addition to the absolute increase in S<sub>tot</sub>, substrate expression, S<sub>tot</sub> (slow regulation), affects signal transmission via S<sub>1</sub> (fast regulation) in a highly ultrasensitive fashion (ultrasensitization), particularly if:</p><disp-formula id="pcbi-0010054-e003"><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.e003" xlink:type="simple"/><!-- <mml:math display='block'><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math> --></disp-formula><p>If this condition holds, signal transmission is negligible (i.e., S<sub>1</sub> &lt;&lt; S<sub>tot</sub>) for weak substrate-expression levels, S<sub>tot</sub> &lt; S<sub>tot,T</sub> (<xref ref-type="fig" rid="pcbi-0010054-g003">Figure 3</xref>), since then virtually all substrate is sequestered on the enzyme–substrate complexes, S<sub>0</sub>K and/or S<sub>1</sub>P (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref>). By contrast, signal transmission begins to rise in an ultrasensitive fashion (ultrasensitization) as soon as the substrate expression exceeds the threshold, i.e., as soon as S<sub>tot</sub> &gt; S<sub>tot,T</sub>. This can be explained as follows: the threshold, S<sub>tot,T</sub>, equals the maximal amount of substrate that can be sequestered on the enzyme–substrate complexes, S<sub>0</sub>K and/or S<sub>1</sub>P (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref>), so that substrate sequestration no longer prevents signal transmission if S<sub>tot</sub> &gt; S<sub>tot,T</sub>. Ultrasensitization finally vanishes for very strong substrate expression (S<sub>tot</sub> &gt;&gt; S<sub>tot,T</sub>), since then the amount of sequestered substrate is negligible, so that substrate expression affects signal transmission in a linear fashion (i.e., S<sub>1</sub> ≈ S<sub>tot</sub>).</p><fig id="pcbi-0010054-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0010054.g003</object-id><label>Figure 3</label><caption><title>Ultrasensitization Due to Substrate Sequestration</title><p>The normalized maximal response of the phosphorylation–dephosphorylation cycle depicted in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B is plotted as a function of substrate expression on a semilogarithmic scale for the limit of strong stimulation (according to <xref ref-type="disp-formula" rid="pcbi-0010054-e001">Equation 1</xref>), where K<sub>tot</sub> &gt;&gt; P<sub>tot</sub>. The threshold, S<sub>tot,T</sub>, (see <xref ref-type="disp-formula" rid="pcbi-0010054-e002">Equation 2</xref>) was varied as indicated, while the Michaelis-Menten constant of the phosphatase, K<sub>M,P</sub>, was kept constant and assumed to be unity. The scheme on the top indicates the mechanism of ultrasensitization: for weak substrate-expression, most of the substrate is sequestered on the enzyme–substrate complexes, S<sub>0</sub>K and S<sub>1</sub>P, while signal transmission via S<sub>1</sub> occurs as soon as substrate expression, S<sub>tot</sub>, exceeds the threshold, S<sub>tot,T</sub>.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.g003" xlink:type="simple"/></fig><p>Thus, we showed that pronounced ultrasensitization due to substrate sequestration on the catalyzing enzymes requires <xref ref-type="disp-formula" rid="pcbi-0010054-e003">Equation 3</xref> to be fulfilled (<xref ref-type="fig" rid="pcbi-0010054-g003">Figure 3</xref>). As outlined in the Discussion, <xref ref-type="disp-formula" rid="pcbi-0010054-e003">Equation 3</xref> is in accordance with experimentally measured data, so that ultrasensitization due to sequestration is expected to be observed in vivo. It should be noted that numerical studies revealed that ultrasensitization due to substrate sequestration under the regime of <xref ref-type="disp-formula" rid="pcbi-0010054-e003">Equation 3</xref> does <italic>not</italic> require very strong stimulation (K<sub>tot</sub> &gt;&gt; P<sub>tot</sub>), which was assumed to derive analytical expressions, but rather can be observed provided that (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref>):</p><disp-formula id="pcbi-0010054-e004"><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.e004" xlink:type="simple"/><!-- <mml:math display='block'><mml:munder><mml:munder><mml:mrow><mml:msub><mml:mn>k</mml:mn><mml:mrow><mml:mtext>cat</mml:mtext><mml:mo>,</mml:mo><mml:mn>K</mml:mn></mml:mrow></mml:msub><mml:mo>&sdot;</mml:mo><mml:msub><mml:mn>K</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy='true'>&!ucub;</mml:mo></mml:munder><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>max</mml:mi><mml:mo></mml:mo><mml:mo>,</mml:mo><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munder><mml:mo>&gt;</mml:mo><mml:munder><mml:munder><mml:mrow><mml:msub><mml:mn>k</mml:mn><mml:mrow><mml:mtext>cat</mml:mtext><mml:mo>,</mml:mo><mml:mn>P</mml:mn></mml:mrow></mml:msub><mml:mo>&sdot;</mml:mo><mml:msub><mml:mn>P</mml:mn><mml:mrow><mml:mtext>tot</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy='true'>&!ucub;</mml:mo></mml:munder><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>max</mml:mi><mml:mo></mml:mo><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munder></mml:math> --></disp-formula><p><xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equation 4</xref> can be considered to be the general requirement for <italic>any</italic> ultrasensitization to occur in a phosphorylation–dephosphorylation cycle, since otherwise kinase activity (i.e., the stimulus) is too weak to elicit significant accumulation of the active species, S<sub>1</sub>. As outlined above, ultrasensitization refers to a large relative increase in signal transmission as the substrate expression level is increased, and thus requires that the majority of substrate is active (i.e., that S<sub>1</sub> ≈ S<sub>tot</sub>) for sufficiently large S<sub>tot</sub>. For such high substrate expression levels, substrate sequestration on the catalyzing enzymes is negligible, and the overall velocities of phosphorylation (S<sub>0</sub> → S<sub>1</sub>) and dephosphorlyation (S<sub>1</sub> → S<sub>0</sub>) can be approximated by V<sub>max,K</sub> and V<sub>max,P</sub>. According to Goldbeter and Koshland [<xref ref-type="bibr" rid="pcbi-0010054-b24">24</xref>], strong signal transmission (i.e., S<sub>1</sub> ≈ S<sub>tot</sub>) for large S<sub>tot</sub>, and thus ultrasensitization, can be observed only if the kinase velocity exceeds that of the phosphatase, i.e., if <xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equation 4</xref> holds (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref>). This result confirms our earlier observation that ultrasensitization vanishes upon weak stimulation (see <xref ref-type="fig" rid="pcbi-0010054-g002">Figure 2</xref>).</p></sec><sec id="s2c"><title>Ultrasensitization Due to Activity Switching</title><p>Even though ultrasensitization due to substrate sequestration is preserved for intermediate stimulus levels (see above), this does not explain why ultrasensitization can be more pronounced for intermediate stimuli when compared to strong stimulation (<xref ref-type="fig" rid="pcbi-0010054-g002">Figure 2</xref>). For intermediate stimulus levels, an additional mechanism, which is independent of substrate sequestration, can bring about enhanced sensitization. Provided that <xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equation 4</xref> holds, increasing substrate expression induces an “activity switch” from high overall phosphatase activity (S<sub>1</sub> → S<sub>0</sub>) to high overall kinase activity (S<sub>0</sub> → S<sub>1</sub>) if kinase catalysis is significantly less saturated than phosphatase catalysis, i.e., if:</p><disp-formula id="pcbi-0010054-e005"><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.e005" xlink:type="simple"/><!-- <mml:math display='block'><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math> --></disp-formula><p>As already mentioned, ultrasensitization refers to a large relative increase in signal transmission as the substrate expression level is increased. While <xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equation 4</xref> is required for strong signal transmission (S<sub>1</sub> ≈ S<sub>tot</sub>) for large S<sub>tot</sub> (see above), <xref ref-type="disp-formula" rid="pcbi-0010054-e005">Equation 5</xref> ensures that signal transmission vanishes (S<sub>1</sub> &lt;&lt; S<sub>tot</sub>) if S<sub>tot</sub> is small: for low substrate expression levels, where enzyme saturation is negligible, the overall phosphorylation and dephosphorylation velocities at steady state can be approximated by linear kinetics with the first-order rate constants V<sub>max,K</sub>/K<sub>M,K</sub> and V<sub>max,P</sub>/K<sub>M,P</sub> (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref>). If <xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equations 4</xref> and <xref ref-type="disp-formula" rid="pcbi-0010054-e005">5</xref> hold, the phosphatase activity outnumbers that of the kinase (i.e., V<sub>max,P</sub>/K<sub>M,P</sub> &gt;&gt; V<sub>max,K</sub>/K<sub>M,K</sub>) provided that the stimulus, K<sub>tot</sub>, is not too strong, so that signal transmission does not occur (S<sub>1</sub> &lt;&lt; S<sub>tot</sub>). Hence, a pronounced relative change from weak to strong signal transmission (ultrasensitization) can be observed as the substrate expression level is increased if both <xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equations 4</xref> and <xref ref-type="disp-formula" rid="pcbi-0010054-e005">5</xref> hold. Importantly, this ultrasensitization due to activity switching is independent of substrate sequestration.</p><p>Corresponding numerical results are shown in <xref ref-type="fig" rid="pcbi-0010054-g004">Figure 4</xref> for a phosphorylation–dephosphorylation cycle with weak substrate sequestration, where intermediary stimulus V<sub>max,K</sub> results in pronounced ultrasensitization due to activity switching. Ultrasensitization disappears for stronger stimulus levels, since then the overall kinase activity outnumbers that of the phosphatase regardless of the substrate expression level (see above). In other words, ultrasensitization due to activity switching is restricted to intermediate stimulus levels, which explains why ultrasensitization in <xref ref-type="fig" rid="pcbi-0010054-g002">Figure 2</xref> is optimal upon intermediate stimulation.</p><fig id="pcbi-0010054-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0010054.g004</object-id><label>Figure 4</label><caption><title>Ultrasensitization Due to Activity Switching</title><p>The normalized response of the phosphorylation–dephosphorylation cycle depicted in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B is plotted as a function of substrate expression on a semilogarithmic scale for varying stimulus levels. To relate the plot to analytical results given in the main text (<xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equation 4</xref>), the stimulus, K<sub>tot</sub>, is expressed as V<sub>max,K</sub> and given in times of V<sub>max,P</sub>. For the parameters chosen (k<sub>on,K</sub> = 0.02; k<sub>off,K</sub> = k<sub>cat,K</sub> = k<sub>off,P</sub> = 1; k<sub>on,P</sub> = 2; k<sub>cat,P</sub> = P<sub>tot</sub> = 0.1), substrate sequestration is insignificant (i.e., <xref ref-type="disp-formula" rid="pcbi-0010054-e003">Equation 3</xref> does <italic>not</italic> hold) and the kinase is significantly less saturated than the phosphatase (<xref ref-type="disp-formula" rid="pcbi-0010054-e005">Equation 5</xref>). The scheme on the top indicates the mechanism of ultrasensitization: increasing substrate expression induces a switch from high overall phosphatase activity (S<sub>1</sub> → S<sub>0</sub>) to high overall kinase activity (S<sub>0</sub> → S<sub>1</sub>).</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.g004" xlink:type="simple"/></fig></sec><sec id="s2d"><title>Ultrasensitization Due to Synexpression within a Kinase Cascade</title><p>Often multiple intermediates in a signaling cascade of phosphorylation–dephosphorylation cycles (<xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>A) are transcribed coordinately in a so-called synexpression group. For example, the insulin receptor and its downstream substrate, IRS-1, are both upregulated during adipocyte differentiation [<xref ref-type="bibr" rid="pcbi-0010054-b08">8</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b25">25</xref>], and this dramatically enhances insulin sensitivity in adipocytes when compared to fibroblastoid precursors. In addition, multiple components of the yeast pheromone-sensing pathway are coordinately induced in a transcriptional positive feedback loop following pheromone stimulation [<xref ref-type="bibr" rid="pcbi-0010054-b19">19</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b26">26</xref>].</p><fig id="pcbi-0010054-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0010054.g005</object-id><label>Figure 5</label><caption><title>Ultrasensitization Due to Synexpression within a Signaling Cascade</title><p>(A) Schematic representation of a signaling cascade subject to synexpression. An increase in the regulator, r, was assumed to result in a proportional increase in the expression of intermediates S and T, both of which are subject to covalent modification by (de)phosphorylation.</p><p>(B) Ultrasensitization due to synexpression within a signaling cascade measured numerically by plotting the normalized response as a function of the regulator concentration, r, where S<sub>tot</sub> = T<sub>tot</sub> = r (solid line). To show that synexpression enhances ultrasensitization, the case where the regulator, r, affects transcription of T only is also shown for S<sub>tot</sub> = 10 (dashed line). Similar results were obtained for other values of S<sub>tot</sub> or other stimulus strengths (data not shown). Parameters chosen: k<sub>off,1</sub> = k<sub>off,5</sub> = k<sub>cat,2</sub> = k<sub>cat,6</sub> = k<sub>off,3</sub> = k<sub>off,7</sub> = k<sub>cat,8</sub> = P<sub>S,tot</sub> = P<sub>T,tot</sub> = 1; k<sub>on,1</sub> = 0.02; k<sub>on,5</sub> = 0.2; k<sub>on,3</sub> = 2.1; k<sub>on,7</sub> = 2; k<sub>cat,4</sub> = 1.1; K<sub>tot</sub> = 10.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.g005" xlink:type="simple"/></fig><p>As the impact of such synexpression groups on signal transmission has not yet been investigated, we analyzed a minimal model, where a transcriptional regulator, r, simultaneously induces the expression of the protein S and its downstream substrate, T, both of which are subject to covalent modification by phosphorylation (<xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>A). For simplicity, we assumed that an increase in the regulator, r, results in a proportional increase in the expression levels of both cascade intermediates, i.e., in S<sub>tot</sub> and T<sub>tot</sub>. Numerical simulations of the model depicted in <xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>A demonstrate that synexpression of S and T (solid line in <xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>B) significantly enhances ultrasensitization when compared to expression of T alone (dashed line in <xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>B). For example, a 3-fold increase in the regulator, r, (indicated by vertical dotted lines) results in a 24-fold increase in the <italic>non</italic>-normalized response, T<sub>1</sub>, if synexpression is assumed, while only a 9-fold increase is observed in a system devoid of synexpression (<xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>B). It should be noted that this enhanced sensitization in <xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>B does <italic>not</italic> result from zero-order ultrasensitivity [<xref ref-type="bibr" rid="pcbi-0010054-b24">24</xref>] of the response, T<sub>1</sub>, with respect to intermediate S<sub>1</sub>, but rather is an inherent property of cascades subject to synexpression.</p><p>The latter conclusion could be confirmed analytically for a simplified kinase cascade model, where substrate sequestration and enzyme saturation were neglected (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd002">Protocol S2</xref>). These analytical studies (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd002">Protocol S2</xref>) revealed that ultrasensitization due to synexpression is observed regardless of the parameters chosen, although the degree of ultrasensitivity is parameter-dependent. As expected, the more cascade stages are coordinately affected by the transcriptional regulator, r, the more pronounced is ultrasensitization due to synexpression (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd002">Protocol S2</xref>). Because the absolute levels of phosphoproteins within kinase cascades often differ substantially, i.e., S<sub>tot</sub> ≠ T<sub>tot</sub> in <xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>A [<xref ref-type="bibr" rid="pcbi-0010054-b27">27</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b28">28</xref>], we were interested in how such differential expression affects ultrasensitization due to synexpression. It turned out that ultrasensitization due to synexpression is most pronounced if the absolute concentrations increase along the cascade, i.e., if S<sub>tot</sub> &lt; T<sub>tot</sub> in <xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>A (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd002">Protocol S2</xref>), as previously reported for the mitogen-activated protein kinase cascade [<xref ref-type="bibr" rid="pcbi-0010054-b27">27</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b28">28</xref>].</p><p>Our modeling studies presented in this section explain why coordinated upregulation of the insulin receptor and its downstream substrate, IRS-1, during adipocyte differentiation results in dramatically enhanced insulin sensitivity (see above). Importantly, ultrasensitization due to synexpression is not restricted to the regulatory mode depicted in <xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>A, but is also observed if multiple deactivators of a signaling cascade are synexpressed (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd002">Protocol S2</xref>) as, for example, observed in fibroblast growth-factor signaling pathways [<xref ref-type="bibr" rid="pcbi-0010054-b29">29</xref>]. Available experimental evidence supports ultrasensitization due to synexpression, since titration with pervanadate, a general inhibitor of protein tyrosine phosphatases, increases Mek phosphorylation in an ultrasensitive fashion [<xref ref-type="bibr" rid="pcbi-0010054-b30">30</xref>], most likely by simultaneously activating multiple tyrosine-phosphorylated proteins including receptors, adaptors, and Mek itself.</p></sec><sec id="s2e"><title>Ultra(de)sensitization Can Bring About Specificity and Modularity</title><p>In the previous sections, we showed that altered substrate expression, S<sub>tot</sub>, can affect signal transmission via phosphorylation–dephosphorylation cycles (see <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B) in a highly ultrasensitive fashion. Likewise, an increase in the phosphatase expression level, P<sub>tot</sub> = P + S<sub>1</sub>P, can decrease signal transmission upon sufficiently strong stimulation in a switch-like manner (<xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>) as suggested by transfection studies in living cells [<xref ref-type="bibr" rid="pcbi-0010054-b23">23</xref>]. This ultrasensitivity, which will be referred to here as “ultra<italic>de</italic>sensitization,” is particularly pronounced if phosphatase catalysis exhibits strong saturation (see <xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref>), i.e., if:</p><disp-formula id="pcbi-0010054-e006"><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.e006" xlink:type="simple"/><!-- <mml:math display='block'><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math> --></disp-formula><p>Here, we propose that ultradesensitization due to induced phosphatase expression results in highly specific regulation of cellular signal transmission provided that <xref ref-type="disp-formula" rid="pcbi-0010054-e006">Equation 6</xref> holds. Consider the scheme depicted in the upper-right corner of <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>, where the unphosphorylated substrate, S, is phosphorylated by three kinases, K<sub>1</sub>, K<sub>2</sub>, and K<sub>3</sub>. According to <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>, signal transmission via K<sub>1</sub> (red line) upon strong stimulation is specifically switched off by a relatively minor increase in the phosphatase expression level, P<sub>tot</sub> = P + S<sub>1</sub>P (indicated by horizontal arrow), while signaling via K<sub>2</sub> (green line) and K<sub>3</sub> (blue line) is essentially unaffected. In other words, ultradesensitization due to phosphatase expression specifically switches off individual signaling crosstalk interactions in a binary fashion if <xref ref-type="disp-formula" rid="pcbi-0010054-e006">Equation 6</xref> holds. The differential sensitivity towards phosphatase expression shown in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref> is due to the fact that catalysis (i.e., k<sub>cat,K</sub> in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B) by K<sub>1</sub> is slower than that by K<sub>2</sub> and K<sub>3</sub>. Further increasing the phosphatase expression sequentially deactivates signaling via K<sub>2</sub> and K<sub>3</sub> as indicated by the vertical dotted lines in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>. Thus, four specific and binary regulatory states can be realized within two orders of magnitude of phosphatase expression, which is the maximal range of transcriptional induction or repression in vivo (e.g., [<xref ref-type="bibr" rid="pcbi-0010054-b19">19</xref>]).</p><p>Although similar specificity can, in principle, also be achieved by reduced expression of the kinases, K<sub>1</sub> through K<sub>3</sub>, phosphatase regulation is advantageous for two reasons. First, induced phosphatase expression (as indicated by the vertical arrow in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>) abolishes K<sub>1</sub>-mediated phosphorylation of S, while leaving other actions of K<sub>1</sub> unaffected, and thereby improves specificity in cellular regulation. Second, transcriptional regulation of phosphatase expression can result in modularization and thereby simplification of cellular regulation: weak phosphatase induction (horizontal arrow in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>) simultaneously downregulates all phosphorylation events that behave like the reaction catalyzed by K<sub>1</sub> (highly sensitive module), while leaving less sensitive modules (blue and green lines in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>) unaffected.</p><fig id="pcbi-0010054-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0010054.g006</object-id><label>Figure 6</label><caption><title>Ultra(de)sensitization Can Bring About Specificity and Modularity</title><p>The response of a phosphorylation–dephosphorylation cycle (see <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B) upon strong stimulation is shown as a function of the phosphatase expression level (P<sub>tot</sub> = P + S<sub>1</sub>P) for varying the ratio of the turnover numbers, k<sub>cat,P</sub>/k<sub>cat,K</sub>. <xref ref-type="disp-formula" rid="pcbi-0010054-e001">Equation 1</xref> was used for plotting, because this expression also applies independently of the relative kinase and phosphatase expression levels provided that K<sub>tot</sub> &gt;&gt; S<sub>tot</sub> and K<sub>tot</sub> &gt;&gt; K<sub>M,K</sub> (see <xref ref-type="supplementary-material" rid="pcbi-0010054-sd001">Protocol S1</xref>). The plots shown correspond to the scheme depicted in the upper-right corner, where the free unphosphorylated substrate, S, is phosphorylated by the three kinases, which differ in their turnover numbers, k<sub>cat,K</sub>: K<sub>1</sub> (red line; k<sub>cat,P</sub>/k<sub>cat,K</sub> = 100), K<sub>2</sub> (green line; k<sub>cat,P</sub>/k<sub>cat,K</sub> = 20), and K<sub>3</sub> (blue line; k<sub>cat,P</sub>/k<sub>cat,K</sub> = 3). As indicated by the vertical dotted lines, ultradesensitization may result in four binary regulatory states depending on the phosphatase expression level, particularly if the phosphatase is strongly saturated with its substrate (<xref ref-type="disp-formula" rid="pcbi-0010054-e006">Equation 6</xref>), which is what we assumed here (K<sub>M,P</sub> = 0.01; S<sub>tot</sub> = 1).</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.g006" xlink:type="simple"/></fig><p>Importantly, similar conclusions regarding selective and modular regulation of phosphorylation events (shown in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>) also hold if a promiscuous phosphatase dephosphorlyates multiple phosphorylation–dephosphorylation cycles [<xref ref-type="bibr" rid="pcbi-0010054-b31">31</xref>–<xref ref-type="bibr" rid="pcbi-0010054-b34">34</xref>] with high affinity (<xref ref-type="disp-formula" rid="pcbi-0010054-e006">Equation 6</xref>). In this case, a minor induction in phosphatase expression is predicted to specifically deactivate all highly sensitive phosphorylation–dephosphorylation cycles (red line in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>), while leaving less sensitive cycles essentially unaffected (blue and green lines in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>). Transfection studies support such differential sensitivity of cellular signaling pathways towards phosphatase expression [<xref ref-type="bibr" rid="pcbi-0010054-b35">35</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b36">36</xref>]. In addition, experimental evidence is consistent with modularization of cellular regulation, since minor alterations in PTB-1B expression were shown to simultaneously affect both cytokine- and insulin-mediated signaling [<xref ref-type="bibr" rid="pcbi-0010054-b32">32</xref>].</p></sec></sec><sec id="s3"><title>Discussion</title><p>Previous research on signal transduction has mainly focused on how hormonal stimulation (fast regulation) alters gene expression (slow regulation). In comparison, the impact of gene expression on the processing of hormonal inputs has been less well investigated, although both types of regulation are intimately coupled (see <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>A). In the work described here, we used computational methods to show that minor alterations in the expression of signaling proteins can result in large changes in steady-state signal transmission. In other words, we showed that slow regulation of signal transduction can affect fast regulation in a highly nonlinear fashion. Because increased signal transmission elicited by transcriptional induction has been referred to as sensitization [<xref ref-type="bibr" rid="pcbi-0010054-b01">1</xref>], we have termed such nonlinearities ultrasensitization.</p><p>Experimental data suggest that gene expression is relatively insensitive towards extracellular stimulation (e.g., [<xref ref-type="bibr" rid="pcbi-0010054-b19">19</xref>]), so that physiological hormone concentrations will affect cellular protein expression only to a minor extent. Biochemical networks exhibiting ultrasensitization transduce such minor changes into large alterations in cellular function, so that ultrasensitization is expected to enhance the effects of extracellular hormone administration. In addition, subthreshold alterations in protein expression (e.g., S<sub>tot</sub> &lt; S<sub>tot,T</sub> in <xref ref-type="disp-formula" rid="pcbi-0010054-e001">Equation 1</xref>) will be neutralized, so that ultrasensitization is predicted to contribute to all-or-none cell-fate decisions.</p><p>If the expression of a protein subject to covalent modification by phosphorylation exhibits stochastic variations (reviewed in [<xref ref-type="bibr" rid="pcbi-0010054-b37">37</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b38">38</xref>]), ultrasensitization can contribute to cellular heterogeneity, which is known to be important in some types of cell differentiation [<xref ref-type="bibr" rid="pcbi-0010054-b37">37</xref>]: provided that the mean expression level is in the range of ultrasensitization (i.e., S<sub>tot</sub> ≈ S<sub>tot,T</sub> in <xref ref-type="disp-formula" rid="pcbi-0010054-e001">Equation 1</xref>), some cells will be highly sensitive towards extracellular growth factors, whereas others will be essentially insensitive. In a related manner, it has been suggested that increased stochasticity in gene expression contributes to haploinsufficiency of tumor-suppressor genes [<xref ref-type="bibr" rid="pcbi-0010054-b39">39</xref>]. In this model, transient reduction of tumor-suppressor function constitutes a window of opportunity for cancer progression. Ultrasensitization might enhance such stochastic effects by transducing relatively minor alterations in gene expression into dramatic changes in tumor-suppressor function. Importantly, ultrasensitization also explains other types of dosage sensitivity, which have been implicated in a variety of diseases. For example, relatively minor overexpression of oncogenic phosphoproteins [<xref ref-type="bibr" rid="pcbi-0010054-b14">14</xref>] is predicted to dramatically affect mitogenic signaling, thereby contributing to carcinogenesis. Finally, strong nonlinearities such as ultrasensitization result in bistability or oscillations when combined with positive [<xref ref-type="bibr" rid="pcbi-0010054-b40">40</xref>] or negative [<xref ref-type="bibr" rid="pcbi-0010054-b41">41</xref>] feedback.</p><p>By analyzing steady-state signal transmission for a given stimulus as a function of protein expression, we showed that alterations in substrate expression can bring about ultrasensitization in a phosphorylation–dephosphorylation cycle (see <xref ref-type="fig" rid="pcbi-0010054-g002">Figure 2</xref>) provided that stimulation is sufficiently strong (<xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equation 4</xref>). Importantly, the kinetic scheme depicted in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B also applies for other types of covalent modification (e.g., acetylation) and for the activation cycles of small G proteins so that ultrasensitization is expected to be a widespread phenomenon in cellular information transfer. Our analytical results demonstrate that ultrasensitization upon strong stimulation requires substrate sequestration on the catalyzing enzymes (<xref ref-type="disp-formula" rid="pcbi-0010054-e003">Equation 3</xref>) to be fulfilled. More specifically, substrate sequestration on the kinase and/or the phosphatase completely prevents signal transmission for weak substrate-expression levels (see <xref ref-type="fig" rid="pcbi-0010054-g003">Figure 3</xref>). As the amount of sequestered substrate cannot exceed the threshold, S<sub>tot,T</sub> (<xref ref-type="disp-formula" rid="pcbi-0010054-e002">Equation 2</xref>), signal transmission begins to rise in an ultrasensitive fashion (ultrasensitization) as soon as the substrate expression level marginally exceeds the threshold expression level, i.e., if S<sub>tot</sub> &gt; S<sub>tot,T</sub> (<xref ref-type="fig" rid="pcbi-0010054-g003">Figure 3</xref>).</p><p>Even though transfection experiments suggest that ultrasensitization occurs in vivo [<xref ref-type="bibr" rid="pcbi-0010054-b23">23</xref>], we asked whether the predicted requirement for ultrasensitization due to substrate sequestration (<xref ref-type="disp-formula" rid="pcbi-0010054-e003">Equation 3</xref>) is in accordance with available enzyme kinetic data. Unfortunately, Michaelis-Menten constants of phosphatases are often measured using nonphysiological substrates such as <italic>p</italic>-nitrophenyl phosphate (i.e., the Michaelis-Menten constants are likely to be lower in vivo), and only very few quantifications of cellular phosphatase concentrations were performed in particular cell types. Nevertheless, available data reveal some candidate phosphatases such as PP1B (K<sub>M,P</sub> = 0.04–10 μM; P<sub>tot</sub> = 0.5 μM) and PP2B (K<sub>M,P</sub> = 2–20 μM; P<sub>tot</sub> = 20 μM), whose cellular concentration P<sub>tot</sub> was reported to exceed the Michaelis-Menten constant K<sub>M,P</sub> [<xref ref-type="bibr" rid="pcbi-0010054-b42">42</xref>]. Likewise, the cellular concentration of PP2A, which has been estimated to be as much as 0.25% of the total cellular protein [<xref ref-type="bibr" rid="pcbi-0010054-b43">43</xref>], exceeds the Michaelis-Menten constant K<sub>M,P</sub> = 10 μM [<xref ref-type="bibr" rid="pcbi-0010054-b44">44</xref>].</p><p>Even though available data suggest that other phosphatases such as PTP-1B (K<sub>M,P</sub> = 0.6–8 μM; P<sub>tot</sub> = 0.02 μM) and PP2C (K<sub>M,P</sub> = 0.1–0.3 μM; P<sub>tot</sub> = 0.01 μM) do not fulfill the condition K<sub>M,P</sub> ≤ P<sub>tot</sub> [<xref ref-type="bibr" rid="pcbi-0010054-b42">42</xref>], it should be kept in mind that subcellular targeting, which has been shown for a variety of phosphatases (e.g., [<xref ref-type="bibr" rid="pcbi-0010054-b33">33</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b34">34</xref>]), is known to dramatically increase the effective phosphatase concentrations. For example, phosphatases usually exhibit 2- to 10-fold higher concentrations in the nucleus than in the cytoplasm [<xref ref-type="bibr" rid="pcbi-0010054-b45">45</xref>]. Likewise, it has been estimated that the effective concentration of signaling proteins is increased by a factor of 1,000 if both the enzyme and the substrate are localized at the membrane [<xref ref-type="bibr" rid="pcbi-0010054-b46">46</xref>]. Finally, the threshold S<sub>tot,T</sub> (i.e., <xref ref-type="disp-formula" rid="pcbi-0010054-e003">Equation 3</xref>) also depends on the ratio of the catalytic rate constants k<sub>cat,P</sub>/k<sub>cat,K</sub> (see <xref ref-type="disp-formula" rid="pcbi-0010054-e002">Equation 2</xref>), which was experimentally measured for the Erk phosphorylation–dephosphorylation cycle and was shown to be 4.1–23.8 for Erk-dephosphorylation by MKP-3, and even higher (41.3–238.1) for Erk-dephosphorylation by HePTP [<xref ref-type="bibr" rid="pcbi-0010054-b47">47</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b48">48</xref>]. Thus, experimental data suggest that ultrasensitization due to substrate sequestration occurs in vivo. Accordingly, association of phosphoproteins with catalyzing enzymes was reported to inhibit cellular signal transmission [<xref ref-type="bibr" rid="pcbi-0010054-b49">49</xref>–<xref ref-type="bibr" rid="pcbi-0010054-b51">51</xref>].</p><p>As shown in <xref ref-type="fig" rid="pcbi-0010054-g002">Figure 2</xref>, ultrasensitization can be even more pronounced for intermediate stimulus levels when compared to very strong stimulation. In this case, an additional mechanism, which is independent of substrate sequestration, contributes to pronounced ultrasensitization upon intermediate stimulation (see <xref ref-type="fig" rid="pcbi-0010054-g004">Figure 4</xref>): increased substrate expression induces an ultrasensitive switch from high overall phosphatase activity (S<sub>1</sub> → S<sub>0</sub>) to high overall kinase activity (S<sub>0</sub> → S<sub>1</sub>) if <xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equations 4</xref> and <xref ref-type="disp-formula" rid="pcbi-0010054-e005">5</xref> hold true. This ultrasensitization due to activity switching is likely to be physiologically relevant, since it simply requires that kinase catalysis is significantly less saturated than phosphatase catalysis (<xref ref-type="disp-formula" rid="pcbi-0010054-e005">Equation 5</xref>), in addition to sufficiently strong stimulation (<xref ref-type="disp-formula" rid="pcbi-0010054-e004">Equation 4</xref>).</p><p>In addition, we proved that coordinated expression of multiple intermediates within a kinase cascade (see <xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>A) results in ultrasensitization due to synexpression (<xref ref-type="fig" rid="pcbi-0010054-g005">Figure 5</xref>B), which is more pronounced the greater the number of intermediates that are expressed coordinately (see <xref ref-type="supplementary-material" rid="pcbi-0010054-sd002">Protocol S2</xref>). Available experimental evidence supports ultrasensitization due to synexpression, since titration with pervanadate, a general inhibitor of protein tyrosine phosphatases, increases Mek phosphorylation in an ultrasensitive fashion [<xref ref-type="bibr" rid="pcbi-0010054-b30">30</xref>], most likely by simultaneously activating multiple tyrosine-phosphorylated proteins, including receptors, adaptors, and Mek itself. Our modeling studies demonstrate that coordinated expression of multiple cascade proteins, e.g., owing to genomic organization in operons, allows more efficient control over cellular signal transduction, when compared to expression of a single rate-limiting protein. This might be one of the reasons why functionally related proteins are frequently expressed in so-called synexpression groups [<xref ref-type="bibr" rid="pcbi-0010054-b52">52</xref>].</p><p>Finally, we showed that induced expression of phosphatases also affects cellular information transfer, i.e., fast regulation, via phosphorylation–dephosphorylation cycles (see <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B) in a highly ultrasensitive fashion (ultradesensitization), particularly if phosphatase catalysis is strongly saturated (<xref ref-type="disp-formula" rid="pcbi-0010054-e006">Equation 6</xref>). Importantly, ultradesensitization can account for specificity and modularity in cellular signal transduction: a minor increase in phosphatase expression may coordinately switch off highly sensitive phosphorylation events, which we collectively referred to as the highly sensitive module (red line in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>), while less sensitive modules (green and blue lines in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>) are essentially unaffected. Thus, depending on the phosphatase expression level, cellular signal transduction can exhibit multiple binary (on/off) regulatory states (vertical dotted lines in <xref ref-type="fig" rid="pcbi-0010054-g006">Figure 6</xref>). The modular model of phosphatase action allows highly flexible regulation of cellular signal transduction, since each phosphatase has a characteristic set of substrates, which partially overlaps with that of other phosphatases, so that most phosphoproteins are dephosphorylated by multiple phosphatases [<xref ref-type="bibr" rid="pcbi-0010054-b31">31</xref>]. Thus, depending on the phosphatase that is induced transcriptionally, each phosphoprotein might be coregulated with different phosphoproteins; that is, the modular organization differs for each phosphatase.</p><p>The paper provides the theoretical framework for more quantitative experimental measurements in order to elucidate the regulation of cellular signal transduction. More specifically, quantitative measurements of how protein expression affects cellular information transfer are highly desirable to understand how haploinsufficiency, specificity, efficiency, bistability, oscillations, noise suppression, and cellular heterogeneity arise. We propose that the predictions made in this paper should be tested experimentally by controlling transcription with recombinant vectors or by the use of transfectants with defined transgene copy numbers. Importantly, it is not sufficient to analyze the phosphorylation status of the protein studied as a measure of signal transmission, since then the potentially inactivating substrate sequestration on the phosphatase (S<sub>1</sub>P-complex in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B) is not taken into account. Thus, kinase-activity assays like that previously described for Erk activity, which uses Erk-induced MBP-phosphorylation as the readout [<xref ref-type="bibr" rid="pcbi-0010054-b53">53</xref>], are needed. We propose to test our predictions experimentally by analyzing the impact of phosphatase expression on Erk-mediated signal transmission for other reasons as well. First, induction of Erk phosphatases owing to transcriptional feedback [<xref ref-type="bibr" rid="pcbi-0010054-b29">29</xref>] or crosstalk [<xref ref-type="bibr" rid="pcbi-0010054-b03">3</xref>] is known to be physiologically important. Second, the Erk–phosphatase complex (S<sub>1</sub>P in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B) is known to be catalytically inactive (e.g., [<xref ref-type="bibr" rid="pcbi-0010054-b22">22</xref>]), which favors ultrasensitization due to substrate sequestration. Third, ultrasensitization (according to <xref ref-type="disp-formula" rid="pcbi-0010054-e003">Equation 3</xref>) is also likely to be observed owing to the low Michaelis-Menten constant of MKP-3 [<xref ref-type="bibr" rid="pcbi-0010054-b48">48</xref>] and to the fact that k<sub>cat,P</sub> &gt;&gt; k<sub>cat,K</sub> (see above).</p><p>As it might be difficult to achieve coordinated expression of multiple phosphoproteins in transfection experiments, ultrasensitization due to synexpression should be further tested using general inhibitors of kinase or phosphatase action. For example, an experimental investigation on the impact of hypoxia, i.e., oxygen depletion, on cellular survival signaling might be physiologically interesting. Hypoxia results in a dramatic decrease in the cellular adenosine triphosphate concentration from ~1 mM to ~20 μM [<xref ref-type="bibr" rid="pcbi-0010054-b54">54</xref>], a value well below the Michaelis-Menten constant for adenosine triphosphate of many kinases, so that the phosphorylation rates of kinases are globally lowered [<xref ref-type="bibr" rid="pcbi-0010054-b55">55</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b56">56</xref>]. Our analytical results (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd002">Protocol S2</xref>) predict that survival signaling mediated by protein kinases exhibits a sharp all-or-none response with respect to cellular adenosine triphosphate levels (i.e., the oxygen concentration), so that extracellular survival factors no longer rescue cells from entering into apoptosis as soon as the oxygen concentration falls below a critical level.</p><p>Our results also emphasize that the impact of gene expression on hormone-induced signal transduction should be further studied theoretically to gain insight into how other signaling modules respond to altered expression of their constituents. For example, explicit calculations (data not shown) reveal that steady-state signal transmission via proteins subject to multisite phosphorylation is much more sensitive towards induced phosphatase expression when compared to the single-site mechanism assumed in <xref ref-type="fig" rid="pcbi-0010054-g001">Figure 1</xref>B. Such further analyses might be done by using metabolic control analysis (reviewed in [<xref ref-type="bibr" rid="pcbi-0010054-b57">57</xref>]), which has been recently applied to understand the impact of gene expression on cellular signaling [<xref ref-type="bibr" rid="pcbi-0010054-b58">58</xref>,<xref ref-type="bibr" rid="pcbi-0010054-b59">59</xref>]. Signals in living cells are often transient (e.g., owing to receptor downregulation). Although our additional calculations reveal that ultrasensitization is preserved for such transient signals (<xref ref-type="supplementary-material" rid="pcbi-0010054-sd003">Protocol S3</xref>), further investigations are needed. Interestingly, strong substrate sequestration in a phosphorylation–dephosphorylation cycle (i.e., S<sub>tot</sub> &lt; S<sub>tot,T</sub> in <xref ref-type="disp-formula" rid="pcbi-0010054-e001">Equation 1</xref>) does not always completely abolish signal transduction, but results in transient signals owing to adaptation (F. Bruggeman and N. Blüthgen, personal communication), if the rate of kinase catalysis (k<sub>cat,K</sub>) is significantly faster than that for substrate sequestration on the phosphatase (k<sub>on,P</sub>). In this case, ultradesensitization due to altered phosphatase expression mainly affects the signal duration rather than the signal amplitude (data not shown), so that further analysis of ultra(de)sensitization may provide insight into how cells regulate mitogenesis versus differentiation [<xref ref-type="bibr" rid="pcbi-0010054-b60">60</xref>].</p></sec><sec id="s4"><title>Materials and Methods</title><p>Numerical simulations were done using the MATLAB computing environment (The Mathworks, Natick, Massachusetts, United States). Analytical results were confirmed using Maple 7 (Waterloo Maple, Waterloo, Ontario, Canada). Computer codes are available from the authors upon request.</p></sec><sec id="s5"><title>Supporting Information</title><supplementary-material id="pcbi-0010054-sd001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.sd001" xlink:type="simple"><label>Protocol S1</label><caption><title>Ultrasensitization in a Phosphorylation–Dephosphorylation Cycle—Mathematical Derivations</title><p>(107 KB PDF)</p></caption></supplementary-material><supplementary-material id="pcbi-0010054-sd002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.sd002" xlink:type="simple"><label>Protocol S2</label><caption><title>Ultrasensitization Due to Synexpression within a Kinase Cascade—Mathematical Derivations</title><p>(50 KB PDF)</p></caption></supplementary-material><supplementary-material id="pcbi-0010054-sd003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0010054.sd003" xlink:type="simple"><label>Protocol S3</label><caption><title>Ultrasensitization is Preserved upon Transient Stimulation</title><p>(283 KB PDF)</p></caption></supplementary-material><sec id="s5a"><title>Accession Numbers</title><p>The Swiss-Prot (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/swissprot" xlink:type="simple">http://www.ebi.ac.uk/swissprot</ext-link>) accession numbers for the proteins discussed in this paper are BRCA1 (P38398), Erk (P27361), H2AX (P16104), HePTP (P35236), insulin (P01308), insulin receptor (P06213), IRS-1 (P35568), MBP (P02686), Mek (Q02750), MKP-1 (P28562), MKP-3 (Q16828), p53 (P04637), PP1B (P62140), PP2A (P67775), PP2B (P16298), PP2C (P35813), pRb (P06400), PTB-1B (P18031), and PTEN (P60484).</p></sec></sec></body><back><ack><p>This work was supported by the Deutsche Forschungsgemeinschaft (SFB 618) and the German Ministry for Research and Education. We thank Frank Bruggeman, Branka Cajavec, Thomas Höfer, René Hoffmann, Michael Ronellenfitsch, and Christine Sers for useful discussions.</p></ack><ref-list><title>References</title><ref id="pcbi-0010054-b01"><label>1</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><name name-style="western"><surname>Herrero</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>WP</given-names></name><name name-style="western"><surname>Antoniv</surname><given-names>TT</given-names></name><name name-style="western"><surname>Falck-Pedersen</surname><given-names>E</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>Sensitization of IFN-gamma Jak-STAT signalling during macrophage activation.</article-title>
					<source>Nat Immunol</source>
					<volume>3</volume>
					<fpage>859</fpage>
					<lpage>866</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b02"><label>2</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ilangumaran</surname><given-names>S</given-names></name><name name-style="western"><surname>Ramanathan</surname><given-names>S</given-names></name><name name-style="western"><surname>Rottapel</surname><given-names>R</given-names></name></person-group>
					<year>2004</year>
					<article-title>Regulation of the immune system by SOCS family adaptor proteins.</article-title>
					<source>Semin Immunol</source>
					<volume>16</volume>
					<fpage>351</fpage>
					<lpage>365</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b03"><label>3</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Pilz</surname><given-names>RB</given-names></name><name name-style="western"><surname>Casteel</surname><given-names>DE</given-names></name></person-group>
					<year>2003</year>
					<article-title>Regulation of gene expression by cyclic GMP.</article-title>
					<source>Circ Res</source>
					<volume>93</volume>
					<fpage>1034</fpage>
					<lpage>1046</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b04"><label>4</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>E</given-names></name><name name-style="western"><surname>van Nimwegen</surname><given-names>E</given-names></name><name name-style="western"><surname>Zavolan</surname><given-names>M</given-names></name><name name-style="western"><surname>Rajewsky</surname><given-names>N</given-names></name><name name-style="western"><surname>Schroeder</surname><given-names>M</given-names></name><etal/></person-group>
					<year>2003</year>
					<article-title>Decay rates of human mRNAs: Correlation with functional characteristics and sequence attributes.</article-title>
					<source>Genome Res</source>
					<volume>13</volume>
					<fpage>1863</fpage>
					<lpage>1872</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b05"><label>5</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Futcher</surname><given-names>B</given-names></name><name name-style="western"><surname>Latter</surname><given-names>GI</given-names></name><name name-style="western"><surname>Monardo</surname><given-names>P</given-names></name><name name-style="western"><surname>McLaughlin</surname><given-names>CS</given-names></name><name name-style="western"><surname>Garrels</surname><given-names>JI</given-names></name></person-group>
					<year>1999</year>
					<article-title>A sampling of the yeast proteome.</article-title>
					<source>Mol Cell Biol</source>
					<volume>19</volume>
					<fpage>7357</fpage>
					<lpage>7368</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b06"><label>6</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Swameye</surname><given-names>I</given-names></name><name name-style="western"><surname>Muller</surname><given-names>TG</given-names></name><name name-style="western"><surname>Timmer</surname><given-names>J</given-names></name><name name-style="western"><surname>Sandra</surname><given-names>O</given-names></name><name name-style="western"><surname>Klingmuller</surname><given-names>U</given-names></name></person-group>
					<year>2003</year>
					<article-title>Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by databased modeling.</article-title>
					<source>Proc Natl Acad Sci U S A</source>
					<volume>100</volume>
					<fpage>1028</fpage>
					<lpage>1033</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b07"><label>7</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Schoeberl</surname><given-names>B</given-names></name><name name-style="western"><surname>Eichler-Jonsson</surname><given-names>C</given-names></name><name name-style="western"><surname>Gilles</surname><given-names>ED</given-names></name><name name-style="western"><surname>Muller</surname><given-names>G</given-names></name></person-group>
					<year>2002</year>
					<article-title>Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors.</article-title>
					<source>Nat Biotechnol</source>
					<volume>20</volume>
					<fpage>370</fpage>
					<lpage>375</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b08"><label>8</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Sesti</surname><given-names>G</given-names></name><name name-style="western"><surname>Federici</surname><given-names>M</given-names></name><name name-style="western"><surname>Hribal</surname><given-names>ML</given-names></name><name name-style="western"><surname>Lauro</surname><given-names>D</given-names></name><name name-style="western"><surname>Sbraccia</surname><given-names>P</given-names></name><etal/></person-group>
					<year>2001</year>
					<article-title>Defects of the insulin receptor substrate (IRS) system in human metabolic disorders.</article-title>
					<source>FASEB J</source>
					<volume>15</volume>
					<fpage>2099</fpage>
					<lpage>2111</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b09"><label>9</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Mellstrom</surname><given-names>B</given-names></name><name name-style="western"><surname>Achaval</surname><given-names>M</given-names></name><name name-style="western"><surname>Montero</surname><given-names>D</given-names></name><name name-style="western"><surname>Naranjo</surname><given-names>JR</given-names></name><name name-style="western"><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group>
					<year>1991</year>
					<article-title>Differential expression of the jun family members in rat brain.</article-title>
					<source>Oncogene</source>
					<volume>6</volume>
					<fpage>1959</fpage>
					<lpage>1964</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b10"><label>10</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Widmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>S</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>GL</given-names></name></person-group>
					<year>1998</year>
					<article-title>Caspase-dependent cleavage of signalling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals.</article-title>
					<source>J Biol Chem</source>
					<volume>273</volume>
					<fpage>7141</fpage>
					<lpage>7147</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b11"><label>11</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>S</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>M</given-names></name><name name-style="western"><surname>Coats</surname><given-names>JK</given-names></name><name name-style="western"><surname>Jones</surname><given-names>Y</given-names></name><name name-style="western"><surname>Martone</surname><given-names>ME</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation.</article-title>
					<source>Neuron</source>
					<volume>36</volume>
					<fpage>507</fpage>
					<lpage>519</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b12"><label>12</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Whitfield</surname><given-names>ML</given-names></name><name name-style="western"><surname>Sherlock</surname><given-names>G</given-names></name><name name-style="western"><surname>Saldanha</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Murray</surname><given-names>JI</given-names></name><name name-style="western"><surname>Ball</surname><given-names>CA</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>Identification of genes periodically expressed in the human cell cycle and their expression in tumors.</article-title>
					<source>Mol Biol Cell</source>
					<volume>13</volume>
					<fpage>1977</fpage>
					<lpage>2000</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b13"><label>13</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Akhtar</surname><given-names>RA</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>AB</given-names></name><name name-style="western"><surname>Maywood</surname><given-names>ES</given-names></name><name name-style="western"><surname>Clayton</surname><given-names>JD</given-names></name><name name-style="western"><surname>King</surname><given-names>VM</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus.</article-title>
					<source>Curr Biol</source>
					<volume>12</volume>
					<fpage>540</fpage>
					<lpage>550</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b14"><label>14</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Blume-Jensen</surname><given-names>P</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>T</given-names></name></person-group>
					<year>2001</year>
					<article-title>Oncogenic kinase signalling.</article-title>
					<source>Nature</source>
					<volume>411</volume>
					<fpage>355</fpage>
					<lpage>365</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b15"><label>15</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Fero</surname><given-names>ML</given-names></name><name name-style="western"><surname>Randel</surname><given-names>E</given-names></name><name name-style="western"><surname>Gurley</surname><given-names>KE</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kemp</surname><given-names>CJ</given-names></name></person-group>
					<year>1998</year>
					<article-title>The murine gene p27Kip1 is haplo-insufficient for tumour suppression.</article-title>
					<source>Nature</source>
					<volume>396</volume>
					<fpage>177</fpage>
					<lpage>180</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b16"><label>16</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Santarosa</surname><given-names>M</given-names></name><name name-style="western"><surname>Ashworth</surname><given-names>A</given-names></name></person-group>
					<year>2004</year>
					<article-title>Haploinsufficiency for tumour suppressor genes: When you don't need to go all the way.</article-title>
					<source>Biochim Biophys Acta</source>
					<volume>1654</volume>
					<fpage>105</fpage>
					<lpage>122</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b17"><label>17</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Fambrough</surname><given-names>D</given-names></name><name name-style="western"><surname>McClure</surname><given-names>K</given-names></name><name name-style="western"><surname>Kazlauskas</surname><given-names>A</given-names></name><name name-style="western"><surname>Lander</surname><given-names>ES</given-names></name></person-group>
					<year>1999</year>
					<article-title>Diverse signalling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes.</article-title>
					<source>Cell</source>
					<volume>97</volume>
					<fpage>727</fpage>
					<lpage>741</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b18"><label>18</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Hazzalin</surname><given-names>CA</given-names></name><name name-style="western"><surname>Mahadevan</surname><given-names>LC</given-names></name></person-group>
					<year>2002</year>
					<article-title>MAPK-regulated transcription: A continuously variable gene switch?</article-title>
					<source>Nat Rev Mol Cell Biol</source>
					<volume>3</volume>
					<fpage>30</fpage>
					<lpage>40</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b19"><label>19</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>B</given-names></name><name name-style="western"><surname>Marton</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Stoughton</surname><given-names>R</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>MR</given-names></name><etal/></person-group>
					<year>2000</year>
					<article-title>Signalling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles.</article-title>
					<source>Science</source>
					<volume>287</volume>
					<fpage>873</fpage>
					<lpage>880</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b20"><label>20</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Legewie</surname><given-names>S</given-names></name><name name-style="western"><surname>Blüthgen</surname><given-names>N</given-names></name><name name-style="western"><surname>Herzel</surname><given-names>H</given-names></name></person-group>
					<year>2005</year>
					<article-title>Quantitative analysis of ultrasensitive responses.</article-title>
					<source>FEBS J</source>
					<volume>272</volume>
					<fpage>4071</fpage>
					<lpage>4079</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b21"><label>21</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>P</given-names></name></person-group>
					<year>2001</year>
					<article-title>The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture.</article-title>
					<source>Eur J Biochem</source>
					<volume>268</volume>
					<fpage>5001</fpage>
					<lpage>5010</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b22"><label>22</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Tanoue</surname><given-names>T</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>E</given-names></name></person-group>
					<year>2000</year>
					<article-title>A conserved docking motif in MAP kinases common to substrates, activators and regulators.</article-title>
					<source>Nat Cell Biol</source>
					<volume>2</volume>
					<fpage>110</fpage>
					<lpage>116</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b23"><label>23</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Lammers</surname><given-names>R</given-names></name><name name-style="western"><surname>Bossenmaier</surname><given-names>B</given-names></name><name name-style="western"><surname>Cool</surname><given-names>DE</given-names></name><name name-style="western"><surname>Tonks</surname><given-names>NK</given-names></name><name name-style="western"><surname>Schlessinger</surname><given-names>J</given-names></name><etal/></person-group>
					<year>1993</year>
					<article-title>Differential activities of protein tyrosine phosphatases in intact cells.</article-title>
					<source>J Biol Chem</source>
					<volume>268</volume>
					<fpage>22456</fpage>
					<lpage>22462</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b24"><label>24</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Goldbeter</surname><given-names>A</given-names></name><name name-style="western"><surname>Koshland</surname><given-names>DE</given-names><suffix>Jr</suffix></name></person-group>
					<year>1981</year>
					<article-title>An amplified sensitivity arising from covalent modification in biological systems.</article-title>
					<source>Proc Natl Acad Sci U S A</source>
					<volume>78</volume>
					<fpage>6840</fpage>
					<lpage>6844</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b25"><label>25</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Rosen</surname><given-names>ED</given-names></name><name name-style="western"><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group>
					<year>2000</year>
					<article-title>Molecular regulation of adipogenesis.</article-title>
					<source>Annu Rev Cell Dev Biol</source>
					<volume>16</volume>
					<fpage>145</fpage>
					<lpage>171</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b26"><label>26</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>MacKay</surname><given-names>VL</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Flory</surname><given-names>MR</given-names></name><name name-style="western"><surname>Turcott</surname><given-names>E</given-names></name><name name-style="western"><surname>Law</surname><given-names>GL</given-names></name><etal/></person-group>
					<year>2004</year>
					<article-title>Gene expression analyzed by high-resolution state array analysis and quantitative proteomics: Response of yeast to mating pheromone.</article-title>
					<source>Mol Cell Proteomics</source>
					<volume>3</volume>
					<fpage>478</fpage>
					<lpage>489</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b27"><label>27</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ferrell</surname><given-names>JE</given-names><suffix>Jr</suffix></name></person-group>
					<year>1996</year>
					<article-title>Tripping the switch fantastic: How a protein kinase cascade can convert graded inputs into switch-like outputs.</article-title>
					<source>Trends Biochem Sci</source>
					<volume>21</volume>
					<fpage>460</fpage>
					<lpage>466</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b28"><label>28</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Yeung</surname><given-names>K</given-names></name><name name-style="western"><surname>Seitz</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Janosch</surname><given-names>P</given-names></name><name name-style="western"><surname>McFerran</surname><given-names>B</given-names></name><etal/></person-group>
					<year>1999</year>
					<article-title>Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.</article-title>
					<source>Nature</source>
					<volume>401</volume>
					<fpage>173</fpage>
					<lpage>177</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b29"><label>29</label><element-citation publication-type="other" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Tsang</surname><given-names>M</given-names></name><name name-style="western"><surname>Dawid</surname><given-names>IB</given-names></name></person-group>
					<year>2004</year>
					<source>Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci STKE 2004: pe17</source>
					<publisher-loc>PMID</publisher-loc>
					<publisher-name>15082862</publisher-name>
				</element-citation></ref><ref id="pcbi-0010054-b30"><label>30</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Diltz</surname><given-names>CD</given-names></name><name name-style="western"><surname>You</surname><given-names>M</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>EH</given-names></name></person-group>
					<year>1996</year>
					<article-title>Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases.</article-title>
					<source>J Biol Chem</source>
					<volume>271</volume>
					<fpage>22251</fpage>
					<lpage>22255</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b31"><label>31</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Tonks</surname><given-names>NK</given-names></name><name name-style="western"><surname>Neel</surname><given-names>BG</given-names></name></person-group>
					<year>2001</year>
					<article-title>Combinatorial control of the specificity of protein tyrosine phosphatases.</article-title>
					<source>Curr Opin Cell Biol</source>
					<volume>13</volume>
					<fpage>182</fpage>
					<lpage>195</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b32"><label>32</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Fukada</surname><given-names>T</given-names></name><name name-style="western"><surname>Tonks</surname><given-names>NK</given-names></name></person-group>
					<year>2003</year>
					<article-title>Identification of YB-1 as a regulator of PTP1B expression: Implications for regulation of insulin and cytokine signalling.</article-title>
					<source>EMBO J</source>
					<volume>22</volume>
					<fpage>479</fpage>
					<lpage>493</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b33"><label>33</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Janssens</surname><given-names>V</given-names></name><name name-style="western"><surname>Goris</surname><given-names>J</given-names></name></person-group>
					<year>2001</year>
					<article-title>Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.</article-title>
					<source>Biochem J</source>
					<volume>353</volume>
					<fpage>417</fpage>
					<lpage>439</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b34"><label>34</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Bollen</surname><given-names>M</given-names></name></person-group>
					<year>2001</year>
					<article-title>Combinatorial control of protein phosphatase-1.</article-title>
					<source>Trends Biochem Sci</source>
					<volume>26</volume>
					<fpage>426</fpage>
					<lpage>431</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b35"><label>35</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Tanoue</surname><given-names>T</given-names></name><name name-style="western"><surname>Moriguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>E</given-names></name></person-group>
					<year>1999</year>
					<article-title>Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5.</article-title>
					<source>J Biol Chem</source>
					<volume>274</volume>
					<fpage>19949</fpage>
					<lpage>19956</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b36"><label>36</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Tanoue</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Maeda</surname><given-names>R</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>E</given-names></name></person-group>
					<year>2001</year>
					<article-title>A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs.</article-title>
					<source>J Biol Chem</source>
					<volume>276</volume>
					<fpage>26629</fpage>
					<lpage>26639</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b37"><label>37</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Fiering</surname><given-names>S</given-names></name><name name-style="western"><surname>Whitelaw</surname><given-names>E</given-names></name><name name-style="western"><surname>Martin</surname><given-names>DI</given-names></name></person-group>
					<year>2000</year>
					<article-title>To be or not to be active: The stochastic nature of enhancer action.</article-title>
					<source>BioEssays</source>
					<volume>22</volume>
					<fpage>381</fpage>
					<lpage>387</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b38"><label>38</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>CV</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>DM</given-names></name><name name-style="western"><surname>Arkin</surname><given-names>AP</given-names></name></person-group>
					<year>2002</year>
					<article-title>Control, exploitation and tolerance of intracellular noise.</article-title>
					<source>Nature</source>
					<volume>420</volume>
					<fpage>231</fpage>
					<lpage>237</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b39"><label>39</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Cook</surname><given-names>DL</given-names></name><name name-style="western"><surname>Gerber</surname><given-names>AN</given-names></name><name name-style="western"><surname>Tapscott</surname><given-names>SJ</given-names></name></person-group>
					<year>1998</year>
					<article-title>Modeling stochastic gene expression: Implications for haploinsufficiency.</article-title>
					<source>Proc Natl Acad Sci U S A</source>
					<volume>95</volume>
					<fpage>15641</fpage>
					<lpage>15646</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b40"><label>40</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ferrell</surname><given-names>JE</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Machleder</surname><given-names>EM</given-names></name></person-group>
					<year>1998</year>
					<article-title>The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes.</article-title>
					<source>Science</source>
					<volume>280</volume>
					<fpage>895</fpage>
					<lpage>898</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b41"><label>41</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Kholodenko</surname><given-names>BN</given-names></name></person-group>
					<year>2000</year>
					<article-title>Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades.</article-title>
					<source>Eur J Biochem</source>
					<volume>267</volume>
					<fpage>1583</fpage>
					<lpage>1588</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b42"><label>42</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GC</given-names></name><name name-style="western"><surname>Kholodenko</surname><given-names>BN</given-names></name></person-group>
					<year>1999</year>
					<article-title>Spatial gradients of cellular phospho-proteins.</article-title>
					<source>FEBS Lett</source>
					<volume>457</volume>
					<fpage>452</fpage>
					<lpage>454</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b43"><label>43</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Goldberg</surname><given-names>Y</given-names></name></person-group>
					<year>1999</year>
					<article-title>Protein phosphatase 2A: Who shall regulate the regulator?</article-title>
					<source>Biochem Pharmacol</source>
					<volume>57</volume>
					<fpage>321</fpage>
					<lpage>328</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b44"><label>44</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>NE</given-names></name><name name-style="western"><surname>Mumby</surname><given-names>MC</given-names></name></person-group>
					<year>2000</year>
					<article-title>Effects of regulatory subunits on the kinetics of protein phosphatase 2A.</article-title>
					<source>Biochemistry</source>
					<volume>39</volume>
					<fpage>11312</fpage>
					<lpage>11318</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b45"><label>45</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Bollen</surname><given-names>M</given-names></name><name name-style="western"><surname>Beullens</surname><given-names>M</given-names></name></person-group>
					<year>2002</year>
					<article-title>Signalling by protein phosphatases in the nucleus.</article-title>
					<source>Trends Cell Biol</source>
					<volume>12</volume>
					<fpage>138</fpage>
					<lpage>145</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b46"><label>46</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Kholodenko</surname><given-names>BN</given-names></name><name name-style="western"><surname>Hoek</surname><given-names>JB</given-names></name><name name-style="western"><surname>Westerhoff</surname><given-names>HV</given-names></name></person-group>
					<year>2000</year>
					<article-title>Why cytoplasmic signalling proteins should be recruited to cell membranes.</article-title>
					<source>Trends Cell Biol</source>
					<volume>10</volume>
					<fpage>173</fpage>
					<lpage>178</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b47"><label>47</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Mansour</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Candia</surname><given-names>JM</given-names></name><name name-style="western"><surname>Matsuura</surname><given-names>JE</given-names></name><name name-style="western"><surname>Manning</surname><given-names>MC</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>NG</given-names></name></person-group>
					<year>1996</year>
					<article-title>Interdependent domains controlling the enzymatic activity of mitogen-activated protein kinase kinase 1.</article-title>
					<source>Biochemistry</source>
					<volume>35</volume>
					<fpage>15529</fpage>
					<lpage>15536</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b48"><label>48</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZX</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Brautigan</surname><given-names>DL</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>ZY</given-names></name></person-group>
					<year>2002</year>
					<article-title>The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases.</article-title>
					<source>J Biol Chem</source>
					<volume>277</volume>
					<fpage>31818</fpage>
					<lpage>31825</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b49"><label>49</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Klingmuller</surname><given-names>U</given-names></name><name name-style="western"><surname>Lorenz</surname><given-names>U</given-names></name><name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name><name name-style="western"><surname>Neel</surname><given-names>BG</given-names></name><name name-style="western"><surname>Lodish</surname><given-names>HF</given-names></name></person-group>
					<year>1995</year>
					<article-title>Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.</article-title>
					<source>Cell</source>
					<volume>80</volume>
					<fpage>729</fpage>
					<lpage>738</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b50"><label>50</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Machide</surname><given-names>M</given-names></name><name name-style="western"><surname>Kamitori</surname><given-names>K</given-names></name><name name-style="western"><surname>Kohsaka</surname><given-names>S</given-names></name></person-group>
					<year>2000</year>
					<article-title>Hepatocyte growth factor-induced differential activation of phospholipase c gamma 1 and phosphatidylinositol 3-kinase is regulated by tyrosine phosphatase SHP-1 in astrocytes.</article-title>
					<source>J Biol Chem</source>
					<volume>275</volume>
					<fpage>31392</fpage>
					<lpage>31398</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b51"><label>51</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Okamura</surname><given-names>H</given-names></name><name name-style="western"><surname>Garcia-Rodriguez</surname><given-names>C</given-names></name><name name-style="western"><surname>Martinson</surname><given-names>H</given-names></name><name name-style="western"><surname>Qin</surname><given-names>J</given-names></name><name name-style="western"><surname>Virshup</surname><given-names>DM</given-names></name><etal/></person-group>
					<year>2004</year>
					<article-title>A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1.</article-title>
					<source>Mol Cell Biol</source>
					<volume>24</volume>
					<fpage>4184</fpage>
					<lpage>4195</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b52"><label>52</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Niehrs</surname><given-names>C</given-names></name><name name-style="western"><surname>Pollet</surname><given-names>N</given-names></name></person-group>
					<year>1999</year>
					<article-title>Synexpression groups in eukaryotes.</article-title>
					<source>Nature</source>
					<volume>402</volume>
					<fpage>483</fpage>
					<lpage>487</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b53"><label>53</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Sturgill</surname><given-names>TW</given-names></name><name name-style="western"><surname>Ray</surname><given-names>LB</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>NG</given-names></name><name name-style="western"><surname>Erickson</surname><given-names>AK</given-names></name></person-group>
					<year>1991</year>
					<article-title>Purification of mitogen-activated protein kinase from epidermal growth factor-treated 3T3-L1 fibroblasts.</article-title>
					<source>Methods Enzymol</source>
					<volume>200</volume>
					<fpage>342</fpage>
					<lpage>351</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b54"><label>54</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Dagher</surname><given-names>PC</given-names></name></person-group>
					<year>2000</year>
					<article-title>Modeling ischemia in vitro: Selective depletion of adenine and guanine nucleotide pools.</article-title>
					<source>Am J Physiol Cell Physiol</source>
					<volume>279</volume>
					<fpage>C1270</fpage>
					<lpage>C1277</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b55"><label>55</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Braunton</surname><given-names>JL</given-names></name><name name-style="western"><surname>Wong</surname><given-names>V</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Salter</surname><given-names>MW</given-names></name><name name-style="western"><surname>Roder</surname><given-names>J</given-names></name><etal/></person-group>
					<year>1998</year>
					<article-title>Reduction of tyrosine kinase activity and protein tyrosine dephosphorylation by anoxic stimulation in vitro.</article-title>
					<source>Neuroscience</source>
					<volume>82</volume>
					<fpage>161</fpage>
					<lpage>170</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b56"><label>56</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Kobryn</surname><given-names>CE</given-names></name><name name-style="western"><surname>Mandel</surname><given-names>LJ</given-names></name></person-group>
					<year>1994</year>
					<article-title>Decreased protein phosphorylation induced by anoxia in proximal renal tubules.</article-title>
					<source>Am J Physiol</source>
					<volume>267</volume>
					<fpage>C1073</fpage>
					<lpage>C1079</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b57"><label>57</label><element-citation publication-type="other" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Heinrich</surname><given-names>R</given-names></name><name name-style="western"><surname>Schuster</surname><given-names>S</given-names></name></person-group>
					<year>1996</year>
					<source>The regulation of cellular systems</source>
					<publisher-loc>New York</publisher-loc>
					<publisher-name>Chapman &amp; Hall</publisher-name>
					<!--===== Restructure page-count as size[@units="page"] =====--><size units="page">372</size>
					<comment>p.</comment>
				</element-citation></ref><ref id="pcbi-0010054-b58"><label>58</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Hornberg</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Bruggeman</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Binder</surname><given-names>B</given-names></name><name name-style="western"><surname>Geest</surname><given-names>CR</given-names></name><name name-style="western"><surname>de Vaate</surname><given-names>AJ</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase/phosphatase control.</article-title>
					<source>FEBS J</source>
					<volume>272</volume>
					<fpage>244</fpage>
					<lpage>258</lpage>
				</element-citation></ref><ref id="pcbi-0010054-b59"><label>59</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>E</given-names></name><name name-style="western"><surname>Salic</surname><given-names>A</given-names></name><name name-style="western"><surname>Kruger</surname><given-names>R</given-names></name><name name-style="western"><surname>Heinrich</surname><given-names>R</given-names></name><name name-style="western"><surname>Kirschner</surname><given-names>MW</given-names></name></person-group>
					<year>2003</year>
					<article-title>The roles of APC and axin derived from experimental and theoretical analysis of the Wnt pathway.</article-title>
					<source>PLoS Biol</source>
					<volume>1</volume>
					<elocation-id>e10.</elocation-id>
					<comment>DOI: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pbio.0000010" xlink:type="simple">10.1371/journal.pbio.0000010</ext-link>.</comment>
				</element-citation></ref><ref id="pcbi-0010054-b60"><label>60</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Marshall</surname><given-names>CJ</given-names></name></person-group>
					<year>1995</year>
					<article-title>Specificity of receptor tyrosine kinase signalling: Transient versus sustained extracellular signal-regulated kinase activation.</article-title>
					<source>Cell</source>
					<volume>80</volume>
					<fpage>179</fpage>
					<lpage>185</lpage>
				</element-citation></ref></ref-list></back></article>